Peptic Ulcer Disease: Physiology and Pathophysiology

Abstract

Medical treatment of peptic ulcer disease has been dramatically altered by the identification and characterization of parietal receptors and by the development of such drugs as histamine H₂-receptor blockers and H-K-ATPases. Progress should enable us to identify persons predisposed to ulcer disease and to prevent its development.